A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients FINE Trial

Tarih
2019
Yazar
Kocer, Belgin
Saip, Sabahattin
Tuncer, Asli
Kasap, Mithat
Caliskan, Zeynep
Akman Demir, Gulsen
Turkoglu, Recai
Yuceyar, Nur
EFENDİ, HÜSNÜ
TURAN, ÖMER FARUK
AĞAN YILDIRIM, KADRİYE
TERZİ, MURAT
BOZ, CAVİT
Üst veri
Tüm öğe kaydını göster
Özet
Introduction: To assess satisfaction and quality of life in patients with relapsing-remitting multiple sclerosis (RRMS) who were receiving fingolimod (0.5 mg/day) for 12 months as a second-line treatment after switching from injectable agents.
Bağlantı
http://hdl.handle.net/20.500.12627/146505
https://doi.org/10.5152/npa.2017.20515
Koleksiyonlar